A5036919997- Cardiac Health and Mental Health
- Atrial Fibrillation Management and Outcomes
- Blood Pressure and Hypertension Studies
- Pharmaceutical Practices and Patient Outcomes
- Antiplatelet Therapy and Cardiovascular Diseases
- Health Systems, Economic Evaluations, Quality of Life
- Acute Myocardial Infarction Research
- Lipoproteins and Cardiovascular Health
- Cardiac Structural Anomalies and Repair
- Venous Thromboembolism Diagnosis and Management
- Cardiovascular Function and Risk Factors
- Meta-analysis and systematic reviews
- Cardiac Valve Diseases and Treatments
- Healthcare cost, quality, practices
- Statistical Methods in Clinical Trials
- Mechanical Circulatory Support Devices
- Diabetes Treatment and Management
- Heart Failure Treatment and Management
University of British Columbia
2017-2025
Vancouver General Hospital
2025
Vancouver Coastal Health
2024
University of Alberta Hospital
2016-2023
Alberta Health Services
2017-2023
Canadian VIGOUR Centre
2019-2023
Alberta Hospital Edmonton
2016-2023
Native Mental Health Association of Canada
2017-2019
Barry University
2019
Background: Patients living in rural settings have poorer access to care and more frequent readmissions after treatment for acute coronary syndrome (ACS) than patients urban settings. It is unclear what types of medication-related issues are encountered by this cohort whether pharmacist-led could resolve them. Objectives: To describe the related cardiac medications ACS impact a virtual follow-up pilot program population. Methods: A quality improvement initiative was developed whereby...
Countless trials are published each year in the field of cardiology.Since many not relevant to pharmacists primary care practice, staying informed current literature is challenging.
We report a case of 56-year-old man requiring HeartMate 3 after myocardial infarction and limited recovery on temporary ventricular assist device. Because several gastrointestinal bleeding complications nonadherence, his antithrombotic therapy was switched from warfarin aspirin to apixaban 5 mg twice daily. also determined peak anti-factor Xa levels for ongoing monitoring. Direct oral anticoagulants may be an option the prevention pump thrombosis in patients who are unable tolerate or refuse therapy.
Abstract Background Pragmatic trials provide results that may be more applicable to the population in which intervention will eventually applied and are discussed extensively current healthcare environment. The aim of this study was investigate how pragmatic or explanatory cardiovascular (CV) randomized controlled (RCT) are, if changing over time, they were less likely meet their primary endpoint. Methods Using six top-ranked (based on impact factors) medical CV journals, all CV-related RCTs...